Healthcare provider profile · identity verified

Robert Freidel

Family Practice · FITCHBURG, WI · NPI 1730685835

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	248	68
Rosuvastatin Calcium	Rosuvastatin Calcium	153	43
Levothyroxine Sodium	Levothyroxine Sodium	129	29
Omeprazole	Omeprazole	122	37
Lisinopril	Lisinopril	117	40
Amlodipine Besylate	Amlodipine Besylate	109	35
Losartan Potassium	Losartan Potassium	93	33
Famotidine	Famotidine	84	23
Eliquis	Apixaban	74	22
Duloxetine Hcl	Duloxetine Hcl	73	19
Metoprolol Succinate	Metoprolol Succinate	73	19
Sertraline Hcl	Sertraline Hcl	68	17
Tamsulosin Hcl	Tamsulosin Hcl	65	19
Gabapentin	Gabapentin	64	12
Hydrochlorothiazide	Hydrochlorothiazide	64	24
Metformin Hcl Er	Metformin Hcl	61	20
Pantoprazole Sodium	Pantoprazole Sodium	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	13
Albuterol Sulfate Hfa	Albuterol Sulfate	36	18
Fluticasone Propionate	Fluticasone Propionate	36	14
Trazodone Hcl	Trazodone Hcl	35	11
Bupropion Xl	Bupropion Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Baclofen	Baclofen	31	suppressed
Naproxen	Naproxen	30	16
Trulicity	Dulaglutide	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	12
Xarelto	Rivaroxaban	28	suppressed
Furosemide	Furosemide	27	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Carvedilol	Carvedilol	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Trokendi Xr	Topiramate	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Valsartan	Valsartan	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Metformin Hcl	Metformin Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	12
Donepezil Hcl	Donepezil Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Prednisone	Prednisone	19	suppressed
Simvastatin	Simvastatin	19	suppressed
Rytary	Carbidopa/Levodopa	18	suppressed
Spironolactone	Spironolactone	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Finasteride	Finasteride	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Atenolol	Atenolol	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Ramelteon	Ramelteon	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Estradiol	Estradiol	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Asenapine Maleate	Asenapine Maleate	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Meloxicam	Meloxicam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error